PRESS-RELEASE ·Filed Jul 9, 2026
Press release · Earnings
NBIX drugs
NBIX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$177.11
T+0 close · Jul 9, 2026 · via day close
Latest settled
−18.58%
T+60 · $144.21
Vs SPY
−21.21%
α at T+60
Horizons
All settled
through T+60
- T+0 · Jul 10 $177.11entry
- T+1 · 4mo ago −1.71%α −0.92% · $174.09
- T+5 · 4mo ago −3.14%α −2.58% · $171.55
- T+20 · 3mo ago −7.74%α −10.16% · $163.41
- T+60 · 6w ago −18.58%α −21.21% · $144.21
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Neurocrine Biosciences, Inc. announced it will host a conference call on July 30, 2026 to discuss its Q2 2026 results.
Key Facts
- Neurocrine Biosciences, Inc. announced it will host a conference call on July 30, 2026 to discuss its Q2 2026 results.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (37 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302822071 |
Track record
30 reports on NBIX
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 2, 202614d ago Press Release Bullish 6/10 No price data
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30
US Market Status
Market Closed · Opens in 7h 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers